![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Two Versions of Generic Glucophage
FDA Approves Two Versions of Generic Glucophage
The FDA has granted final approval to Andrx and Alpharma to market generic versions of Bristol-Myers Squibb's diabetes drug Glucophage (metformin HCl).
Both companies were cleared to begin selling metformin HCl extended-release 750-mg tablets. Andrx said it has already commenced shipments of the product. Alpharma said it will launch its product immediately.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct